Bedside Snapshot
- Normal / Therapeutic
- Not detected (lab cutoff often 10 mg/dL). No therapeutic range, except as a toxic-alcohol antidote set by toxicology. US per-se driving limit 80 mg/dL (0.08%) whole blood or breath; lower in Utah, commercial and under-21 drivers
- Toxic Thresholds
- Critical: >250 mg/dL (54.3 mmol/L), typical; lab-specific
- >400 mg/dL: coma, respiratory depression, death if non-tolerant
- Tolerant drinkers may be awake above 400
- Young children: hypoglycemia at low levels
- Toxicity Looks Like
- Slurred speech, ataxia, nystagmus, vomiting; then stupor, hypothermia, slow breathing, aspiration, coma. Young children: hypoglycemia, seizures, hypothermia
- Antidote / Definitive Care
- No antidote. Airway and ventilation support, dextrose for low glucose, thiamine for at-risk adults, warming, observation to clinical sobriety. Hemodialysis only for rare extreme cases
- Act Now If
- Hypoventilation, falling GCS, glucose <70 mg/dL, head injury, or an exam the level does not explain: support airway and breathing, give dextrose, CT head, search for co-ingestants
- Watch Out For
- Calling it just alcohol: a patient not improving as the level falls (about 15–20 mg/dL per hr) has another problem until proven otherwise
Reference & Critical Ranges
Lab-specific ranges: Every lab sets its own range. It shifts with the analyzer and the population. Use the range on your report. The numbers below are typical.
Reference ranges
| Population | Conventional | SI | Notes |
|---|---|---|---|
| Adult | Not detected | Not detected | Below the laboratory's reporting cutoff (often 10 mg/dL, 0.010%). Any measurable level means recent ethanol exposure |
| Pregnancy | Not detected | Not detected | Same interpretation; no level of drinking is known to be safe for the fetus |
| Children | Same as adult | Same as adult | Any detectable level in a young child is significant: check glucose and ask how the child got the ethanol |
Severity & critical values
| Level | Concentration | When to draw | Meaning (non-tolerant adult) |
|---|---|---|---|
| Not detected | Below the lab cutoff (often <10 mg/dL; <2.2 mmol/L) | On arrival in any altered or injured patient | No recent drinking. Ethanol does not explain an abnormal exam; withdrawal is still possible in a heavy drinker |
| Mild | 50–100 mg/dL (10.9–21.7 mmol/L) | — | Impaired judgment, coordination and reaction time. The usual US per-se driving limit (80 mg/dL, 0.08%, in whole blood or breath; about 93 mg/dL in serum) sits here. Utah uses 50 mg/dL; commercial drivers 40 mg/dL; drivers under 21 face zero-tolerance laws |
| Moderate | 100–200 mg/dL (21.7–43.4 mmol/L) | — | Unsteady gait, slurred speech, mood and behavior change |
| Severe | 200–400 mg/dL (43.4–86.8 mmol/L) | Repeat with the exam if the patient is not improving | Vomiting, hypothermia, amnesia, diplopia, nystagmus; aspiration risk; stupor toward the upper end |
| Critical | >250 mg/dL (54.3 mmol/L); typical, lab-specific | Laboratory calls the result | Reassess airway reflexes, ventilation, glucose and temperature now |
| Life-threatening | >400 mg/dL (86.8 mmol/L) | Repeat with the exam if the patient is not improving | Respiratory depression, coma and death in non-tolerant patients. A tolerant drinker may be awake at this level |
Critical values: >250 mg/dL (54.3 mmol/L) is a typical critical value. The lab sets the real cutoff, and some labs use 300 or higher. Above 400 mg/dL (86.8 mmol/L), respiratory depression, coma and death are expected in a non-tolerant patient. Tolerance moves every band. Treat the patient's airway, breathing and glucose. Not the number.
Conversion: mg/dL × 0.217 = mmol/L; g/dL (BAC %) × 1,000 = mg/dL (0.08% = 80 mg/dL).
Ethanol contribution to the osmolal gap
Ethanol (mg/dL) ÷ 3.7 = mOsm/kg (SI: 1.25 × ethanol in mmol/L)
Subtract ethanol's share. A residual gap above about 10 mOsm/kg points to another osmole, such as methanol or ethylene glycol.
Causes of Abnormal Results
A detectable level means exposure. The question that matters is whether ethanol explains the patient. And what else is it hiding or causing?
Sources & routes of exposure
| Source | Examples | Bedside clue |
|---|---|---|
| Beverage alcohol | Beer, wine, spirits; binge drinking | Most adult and adolescent ED presentations. Ask about amount, timing and co-ingestants |
| Hand sanitizers | Gels and foams with 60–95% ethanol or isopropanol | Young children (unsupervised) and adults without access to beverage alcohol. Some contain isopropanol instead |
| Mouthwash, perfume, cologne | Household and personal-care products | Toddlers: small volumes can cause hypoglycemia and coma |
| Medicines and extracts | Cough and cold liquids, cooking extracts | Hidden source in children; read the label for alcohol content |
| Given to a child by someone else | Unintentional or malicious administration | Unexplained exposure in an infant or toddler: involve child protection per local policy |
| Endogenous (rare) | Auto-brewery syndrome: gut yeast ferment carbohydrate | Recurrent detectable levels with credible denial of drinking; a diagnosis of exclusion |
Risk factors for toxicity
| Factor | Why it matters | Practical point |
|---|---|---|
| Young child | Small glycogen stores plus ethanol's block on gluconeogenesis | Profound hypoglycemia, hypothermia and coma after small amounts |
| No tolerance | Adolescents and occasional drinkers have no adaptive tolerance | Coma and respiratory depression at levels a heavy drinker tolerates |
| Fast, concentrated drinking | Spirits on an empty stomach give a faster, higher peak | Drinking games and shots: the level may still be rising on arrival |
| Sedative or opioid co-ingestion | Additive CNS and respiratory depression | Exam worse than the level: suspect a co-ingestant |
| Fasting, malnutrition, liver disease | Depleted glycogen; impaired gluconeogenesis | Hypoglycemia and ketoacidosis; check glucose repeatedly |
| Female sex, older age | Less total body water: higher level from the same dose | Older adults also fall and bleed more |
Acute vs acute-on-chronic vs chronic
| Feature | Acute (non-tolerant) | Acute-on-chronic (tolerant) | After heavy use stops |
|---|---|---|---|
| Level vs exam | Exam roughly tracks the level | Awake, talking at levels that sedate others | Low or zero level; tremor, sweating, agitation |
| Main dangers | Airway, aspiration, hypoventilation, hypothermia, trauma | Head injury, Wernicke encephalopathy, withdrawal as the level falls | Withdrawal seizures and delirium; alcoholic ketoacidosis |
| Glucose | Low in children and fasting patients | Low, normal or high | Low, normal or mildly high in ketoacidosis |
| Other labs | Usually normal | Low K⁺, Mg²⁺ and phosphate; raised AST/ALT, MCV and GGT | Anion gap acidosis with β-hydroxybutyrate (alcoholic ketoacidosis) |
| Key action | Airway, glucose, observe | Thiamine, electrolytes, withdrawal risk screen | Treat withdrawal; fluids with dextrose, thiamine and electrolytes for ketoacidosis |
Not just drunk: Behind a positive level can sit a head injury, hypoglycemia, a co-ingestant, toxic alcohols, sepsis, seizure, or hepatic or Wernicke encephalopathy. Don't pin the altered mental status on ethanol unless the level fits the exam and the patient improves as it falls.
Interpretation & Bedside Approach
Step-by-step approach
- Is it real? Hospital results come from serum or plasma. Those run about 16% higher than whole blood or breath (legal) values. The level falls every hour, so write down the draw time. An alcohol-prepped site or an uncapped tube can mislead you.
- How sick is the patient? Start with the airway reflexes, ventilation (waveform EtCO₂), point-of-care glucose, temperature and injuries. The exam outranks the number.
- Does the level explain the exam? Deep coma with a low level points to another cause. A high level in a talking patient points to tolerance and a risk of withdrawal.
- Calculate derived values: anion gap and, when toxic alcohols are possible, the osmolal gap with the ethanol term (Reference & Critical Ranges).
- Classify: acute intoxication, acute-on-chronic, withdrawal (ASAM 2020 guideline), alcoholic ketoacidosis or a toxic alcohol (GOLDMARK for anion gap acidosis).
- Reassess and dispose: As the level falls about 15–20 mg/dL each hour, the exam should improve. No improvement means CT of the head and a broader workup. Discharge on clinical sobriety, not on a number.
Patterns
| Pattern | Suggests | Next step |
|---|---|---|
| Level fits the exam, patient improving | Uncomplicated intoxication | Observe to clinical sobriety; screen for alcohol use disorder |
| Exam worse than the level, or not improving as it falls | Head injury, hypoglycemia, co-ingestant, toxic alcohol, infection, postictal state | Glucose, CT head, co-ingestant screen, blood gas, osmolal gap |
| High level, minimal impairment | Tolerance from regular heavy drinking | Assess withdrawal risk (PAWSS or similar); thiamine |
| Withdrawal signs with a positive level | Higher risk of severe or complicated withdrawal | Treat withdrawal; a positive level does not rule it out |
| Anion gap acidosis, low or zero ethanol, vomiting after a binge | Alcoholic ketoacidosis | β-hydroxybutyrate, lactate, glucose; exclude toxic alcohols |
| Residual osmolal gap >10 after the ethanol term | Methanol, ethylene glycol or isopropanol | Toxic alcohol levels; fomepizole per toxicology |
Rough time to reach a lower level
Hours ≈ (current level − target level) ÷ 15–20 mg/dL per hr
Example: 260 mg/dL falls to about 80 mg/dL in roughly 9–12 hr. Elimination varies from 10 to 35 mg/dL per hr. Use this for planning only. Decide disposition at the bedside.
Ethanol delays toxic-alcohol acidosis: Ethanol ties up alcohol dehydrogenase, so methanol or ethylene glycol gets broken down slowly while ethanol is still on board. A normal anion gap with a high ethanol level does not rule out a toxic alcohol. The acidosis may show up only as the ethanol clears.
Management Priorities
Emergency: Depressed consciousness with a positive ethanol level
- Airway and breathing: recovery position, suction, oxygen to SpO₂ target; bag-mask ventilation for hypoventilation; waveform EtCO₂. Advanced airway if reflexes are absent (Paramedic/RN/CCT, per local protocol).
- Glucose: point-of-care glucose on every patient. Below 70 mg/dL: give dextrose now; do not delay dextrose for thiamine, give thiamine with or soon after dextrose.
- Look for the second problem: injuries and spinal motion restriction per protocol, CT head when the history is unclear or the exam does not improve, naloxone for an opioid toxidrome, temperature, seizure activity.
- Monitor and repeat: SpO₂, EtCO₂, temperature, glucose and serial neuro exams. Repeat the level only if the exam does not fit.
Emergency: Young child with an ethanol exposure
- Glucose first and often: hypoglycemia can be delayed and profound; treat with D10. The pediatric treatment threshold varies by protocol (commonly below 60–70 mg/dL); follow local pediatric protocol.
- Support: airway and ventilation, warming, IV fluids for dehydration or hypotension.
- Call: Poison Control 1-800-222-1222; observe in hospital until awake with a stable glucose.
- Protect: unexplained exposure in an infant or toddler needs a safety assessment per local policy.
Medications
Doses vary by protocol; follow local protocols and medical direction.
| Drug | Adult dose | Pediatric dose (max) | Onset / key notes |
|---|---|---|---|
| Dextrose (D10 preferred) | Glucose <70 mg/dL and cannot swallow: 10 g IV/IO (100 mL D10), repeat until alert (field max 25 g, then per medical direction). D50 alternative: 10–25 g slow IV into a large vein | 0.5–1 g/kg IV/IO as D10 5–10 mL/kg; max 25 g/dose | Never delay for thiamine. D50 (≥20%) is High-alert. Recheck glucose after each dose |
| Thiamine | At risk (heavy drinking, malnutrition): 100 mg IV/IM daily for 3–5 days. Suspected Wernicke encephalopathy: 500 mg IV every 8 hr (regimens vary from 200 mg three times daily), at least 3 days | Not routinely used (consult): no evidence-based pediatric dose, and isolated ingestion does not need it | Do not delay dextrose for thiamine. In at-risk patients give thiamine with or soon after dextrose. IV/IM preferred over PO |
| Naloxone | Suspected opioid co-ingestion with hypoventilation: 0.2–2 mg IV/IO/IM or 2–4 mg IN, every 2–3 min, titrated to breathing (no fixed max) | 0.1 mg/kg IV/IO; max 2 mg/dose | Does not reverse ethanol. Ventilate first; titrate to breathing, not alertness |
| Lorazepam | Alcohol withdrawal seizure: 2 mg IV once, then treat the withdrawal per symptom-triggered (CIWA-Ar) protocol | Not routinely used (consult) | Respiratory depression risk. A high ethanol level adds sedation: count every benzodiazepine dose |
| Diazepam | Alcohol withdrawal: 10 mg IV/IM, then 5–10 mg in 3–4 hr if needed (label). Severe withdrawal: IV front-loading titrated to light somnolence per ED/ICU protocol (no fixed max) | Not routinely used (consult) | Respiratory depression risk. Continuous SpO₂ and EtCO₂ with repeated IV doses |
| Phenobarbital | Moderate to severe withdrawal, being admitted (ED adjunct): 10 mg/kg IV once with symptom-triggered benzodiazepines, no faster than 60 mg/min. Weight basis is ideal body weight in the ED study cited by protocols, in 100 mL NS over about 30 min; do not dose by actual weight in obesity without protocol direction | Not routinely used (consult) | Off-label. Monitored setting only; avoid in patients already heavily sedated or with respiratory compromise, and avoid stacking with large benzodiazepine doses |
Sedatives on top of ethanol: Benzodiazepines and phenobarbital add to ethanol's respiratory depression. Use a pump or a second-clinician check for IV infusions and every pediatric dose, give continuous SpO₂ and waveform EtCO₂, and have bag-mask ventilation ready.
Agitated intoxicated patient
- Check first: glucose and hypoxia (EMT and up). Look for trauma and co-ingestants.
- De-escalate: calm, consistent, low-stimulus approach (EMT and up).
- Sedation (Paramedic and RN, per local protocol): treat with monitoring of SpO₂, EtCO₂ and mental status. Ketamine or antipsychotics add respiratory and, for antipsychotics, QT risk; check the ECG per protocol.
- Restraint: avoid prone restraint and restraint that compresses the chest; restrain only as local policy allows, with a clinician monitoring airway and breathing.
Definitive care & disposition
- No antidote: care is supportive. IV fluids treat dehydration or hypotension; there is no good evidence that they speed ethanol clearance.
- Clinical sobriety for discharge: baseline mental status, steady gait, protecting the airway, tolerating fluids, and a safe plan. Base psychiatric assessment on cognition, not on a set level.
- Admit or ICU: airway support or aspiration, persistent altered mental status, hypothermia, Wernicke encephalopathy, alcoholic ketoacidosis, or moderate to severe withdrawal.
- Hemodialysis: removes ethanol efficiently but is rarely needed; consider only for extreme toxicity with organ dysfunction despite full support, with toxicology and nephrology.
- Every intoxicated patient: screen for alcohol use disorder and connect to treatment; children and adolescents need follow-up for how the exposure happened.
Doses are typical references. Follow local protocols, medical direction and institutional policy.
Field & Transport Considerations
Point-of-care testing
No field test measures blood ethanol. A breath device estimates whole-blood ethanol, but it needs a cooperative patient. It is unreliable after recent drinking or vomiting. The tools that matter in the field are the glucometer, a thermometer and waveform EtCO₂ for hypoventilation.
Before and during interfacility transport
| Setting | Consideration |
|---|---|
| EMS scene | Glucose on every altered patient; look for trauma, cold exposure, pill bottles and non-beverage products. Decision-making capacity and refusals follow local protocol |
| Sending facility | Send the ethanol level with its draw time, glucose results, CT findings, thiamine and dextrose times, every benzodiazepine dose and the latest withdrawal score |
| En route | Recovery position or secured airway, suction ready, continuous SpO₂ and EtCO₂, warming. Recheck glucose if mental status changes or the trip is long |
| Trending | Expect improvement as the level falls. A patient who stays down or worsens needs a new cause: tell the receiving team |
Timing & Kinetics
| Parameter | Value | Clinical implication |
|---|---|---|
| Peak after drinking | Usually 10–60 min on an empty stomach; later and lower with food | A patient seen soon after heavy drinking may still be rising: reassess |
| Volume of distribution | About 0.7 L/kg in men, 0.6 L/kg in women (total body water) | Women, older adults and smaller patients reach higher levels from the same dose |
| Kinetics | Zero-order once alcohol dehydrogenase saturates (above about 15–20 mg/dL) | The level falls by a fixed amount per hour, not by half |
| Elimination rate | About 15–20 mg/dL per hr (range 10–35); faster in heavy drinkers | Estimate time to clear for planning only (Interpretation) |
| Neonates | About half the adult elimination rate | Prolonged effect; admit and monitor glucose |
| Breath test window | Roughly 1 standard drink is cleared per hr | Heavy drinkers clear faster: a negative breath test does not exclude withdrawal risk |
| Withdrawal onset | Symptoms 6–24 hr after the last drink (may start with a positive level); seizures 8–48 hr, peak about 24 hr; hallucinosis 12–24 hr | Reassess with a withdrawal scale as the level falls |
| Withdrawal delirium | Usually 2–4 days after the last drink (range about 1–5 days); lasts 2–3 days | Plan admission for patients at high risk before it starts |
Serum is not whole blood: Most published rates and legal limits assume whole blood. Serum reads about 16% higher, so about 93 mg/dL on a hospital report matches 80 mg/dL whole blood.
Special Populations
| Population | What changes | Clinical implication |
|---|---|---|
| Neonates & infants | Low glycogen stores; slower elimination | Profound hypoglycemia, hypothermia and coma after small exposures; admit, glucose checks, D10 |
| Children & adolescents | No tolerance; hand sanitizer, mouthwash and household products in young children; binge drinking in teens | Check glucose in every case. Teens: look for co-ingestants, trauma and assault; screen and refer |
| Pregnancy | Ethanol crosses the placenta; risk of fetal alcohol spectrum disorder | Same acute care. Withdrawal: consider inpatient care for all, offer it at CIWA-Ar ≥10, consult obstetrics; benzodiazepines are the usual treatment; phenobarbital in pregnancy is off-label with limited data and needs obstetric and toxicology input |
| Older adults | Less total body water: higher level per drink; more sensitive to sedation | Falls, subdural hematoma and delirium; withdrawal may follow a different timeline |
| Chronic heavy drinkers | Tolerance and faster elimination; thiamine, magnesium and phosphate depletion | Awake at high levels; high withdrawal and Wernicke risk; thiamine for all |
| Liver disease | Hepatic encephalopathy, coagulopathy, low glycogen | Encephalopathy mimics intoxication; hypoglycemia and bleeding more likely |
Sex differences: Women have a smaller volume of distribution (about 0.6 vs 0.7 L/kg). Same number of drinks, higher level.
Interfering Factors & Pitfalls
Collection & handling
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Alcohol-based skin prep | ↑ possible | Contamination of the sample | Minimal effect in practice; non-alcohol cleanser is standard, and required for forensic draws |
| Uncapped or underfilled tube, delay | ↓ | Ethanol is volatile and evaporates | Cap tightly, separate serum promptly, send without delay |
| Unpreserved sample with glucose and microbes | ↑ | Yeast or bacteria ferment glucose to ethanol in the tube (mainly postmortem and urine samples) | Gray-top sodium fluoride tube when storage or forensic testing is expected |
| Draw time not recorded | Misread | The level falls 15–20 mg/dL each hour | Document the draw time with every result |
Physiologic / biologic
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| High lactate and LDH | False + (theoretical) | Enzymatic assays measure NADH, which LDH also generates from lactate | Reported in postmortem and resuscitated-infant samples, not shown in live ED patients; confirm by gas chromatography if it matters |
| Auto-brewery syndrome | ↑ (true) | Gut yeast ferment carbohydrate to ethanol | Rare; consider only after excluding hidden drinking |
Assay & device-specific
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Serum vs whole blood vs breath | Serum about 16% higher | Serum holds more water than whole blood | Never compare a hospital serum level directly with a legal limit |
| Other alcohols (methanol, ethylene glycol, isopropanol) | Not measured | The ethanol assay is specific for ethanol | Order toxic-alcohol levels or use the osmolal gap |
Common misinterpretations
- “The level explains the coma”: Only when it fits the exam and the patient improves as it falls.
- “Legal limit, so safe to go”: Disposition rests on clinical sobriety and a safe plan.
- “Positive level, so no withdrawal”: Withdrawal can begin while ethanol is still measurable.
- “Negative ethanol, so no alcohol problem”: Toxic alcohols, alcoholic ketoacidosis and withdrawal all happen at low or zero levels.
Draw it right: Use a non-alcohol skin prep, cap the tube and record the draw time for any result that may be used clinically or legally.
Physiology & Test Basics
What it measures
This is the ethanol (ethyl alcohol) concentration in serum or plasma, and only that. It cannot see methanol, ethylene glycol or isopropanol (see Toxic Alcohols). It says nothing about tolerance, dependence or recent cessation.
Physiology & regulation
- Absorption: It moves fast from the stomach and especially the small intestine. Gastric emptying sets the pace.
- Distribution: It spreads through total body water. Fat holds almost none.
- Metabolism: The liver does 92–98% of it. Alcohol dehydrogenase makes acetaldehyde, and aldehyde dehydrogenase turns that into acetate. CYP2E1 adds capacity in heavy drinkers.
- Excretion: 2–10% leaves unchanged in breath, urine and sweat. That is the basis of breath testing.
- Metabolic effects: A raised NADH/NAD⁺ ratio blocks gluconeogenesis. The result is hypoglycemia. It also favors lactate and β-hydroxybutyrate.
- CNS effects: Ethanol enhances GABA and blocks NMDA signaling. Chronic use up-regulates excitatory pathways. That drives withdrawal.
How it is measured
- Specimen: serum or plasma (red top, or gray-top sodium fluoride/potassium oxalate; EDTA acceptable at some labs). Legal testing often uses whole blood with chain of custody.
- Collection: non-alcohol skin cleanser; fill and cap the tube; record the draw time.
- Method: Hospital analyzers run an enzymatic alcohol dehydrogenase assay as a STAT test. Reference and forensic labs use gas chromatography.
- Units: US hospitals report serum mg/dL. Legal results come in g/dL (%) of whole blood, or a breath equivalent.
Why it matters
Intoxication shows up often in the ED and in trauma, and it hides serious illness. A measured level shows whether ethanol can explain the patient. It flags tolerance and withdrawal risk, and it is needed to interpret the osmolal gap.
Clinical Pearls
Treat the patient, not the number: Tolerance makes the number a poor guide to danger. What decides care: airway reflexes, ventilation, glucose and the trend of the exam.
No improvement means a second problem: The level falls about 15–20 mg/dL each hour. A patient who is not waking as expected needs a CT of the head, a glucose check, a co-ingestant search and a toxic-alcohol check.
Dextrose and thiamine in any order: Never hold dextrose for a hypoglycemic patient while you wait on thiamine. In at-risk patients, give thiamine with or soon after dextrose. Everyone at risk of Wernicke encephalopathy needs thiamine.
A sober-looking patient with a high level: A patient talking clearly at a high level has tolerance from heavy daily drinking. As the level falls, expect withdrawal. Screen for that risk early.
Children and household products: A toddler can go into hypoglycemic coma from hand sanitizer, mouthwash or perfume. Check glucose on arrival, and keep checking. Then observe in hospital.
Transport handoff: Hand over the level with its draw time, the glucose values and times, the thiamine and dextrose given, and every benzodiazepine dose. The receiving team needs the trend, not just the number.
Nursing: reassess on a schedule: Run serial neuro checks, and track SpO₂, EtCO₂, temperature and glucose. Once symptoms appear, use a withdrawal scale such as CIWA-Ar. Count every sedative dose against the ethanol already on board.
References
- American Society of Addiction Medicine. (2020). The ASAM clinical practice guideline on alcohol withdrawal management. Journal of Addiction Medicine, 14(3S Suppl 1), 1–72. https://doi.org/10.1097/ADM.0000000000000668
- LaHood, A. J., & Kok, S. J. (2023). Ethanol toxicity. In StatPearls (updated June 21, 2023). StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557381/
- Jones, A. W. (2019). Alcohol, its absorption, distribution, metabolism, and excretion in the body and pharmacokinetic calculations. WIREs Forensic Science, 1(5), e1340. https://doi.org/10.1002/wfs2.1340
- Perry, P. J., Doroudgar, S., & Van Dyke, P. (2017). Ethanol forensic toxicology. Journal of the American Academy of Psychiatry and the Law, 45(4), 429–438. https://jaapl.org/content/45/4/429
- Long, B., Lentz, S., & Gottlieb, M. (2021). Alcoholic ketoacidosis: Etiologies, evaluation, and management. Journal of Emergency Medicine, 61(6), 658–665. https://doi.org/10.1016/j.jemermed.2021.09.007
- Hon, K. L., Leung, A. K., Cheung, E., Lee, B., Tsang, M. M., & Torres, A. R. (2018). An overview of exposure to ethanol-containing substances and ethanol intoxication in children based on three illustrated cases. Drugs in Context, 7, 212512. https://doi.org/10.7573/dic.212512
- Purssell, R. A., Pudek, M., Brubacher, J., & Abu-Laban, R. B. (2001). Derivation and validation of a formula to calculate the contribution of ethanol to the osmolal gap. Annals of Emergency Medicine, 38(6), 653–659 (landmark derivation). https://doi.org/10.1067/mem.2001.119455
- ARUP Laboratories. (2026). Ethanol, serum or plasma – medical (test 0090120): specimen requirements, toxic level and interpretive data. ARUP Laboratory Test Directory. https://ltd.aruplab.com/Tests/Pub/0090120
Medical Disclaimer
- For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
- Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
- Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.
AI Assistance Notice
AI was used to assist in organizing, paraphrasing, and formatting this information.